PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12182627::ACT019138

C1

Evidence text

Paper-level observation

Neither C1 nor C2 peptide offered protection to Vero cells in the cell-pretreatment assay.
textConfidence: high

Assay observation

Activity
Antiviral
Subtype
Anti-HSV
Measure
qualitative
Comparator
unknown
Raw observation
no protection
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Vero
Assay method
Cell pretreatment assay
Sequence
LQYPDDSDDE
Standardization
ready simple
Assay conditions
"Vero cells pretreated with peptide for 1 h at 37 °C, then washed and infected with 10 TCID50 virus for 2 h. MTT readout after 5 days."

Source publication

Uncovering the Anti-Herpetic Activity of Anionic Peptides Derived From the Cytoplasmic Domain of Nectin-1.

Bioinformatics and Biology Insights · 2025

DOI 10.1177/11779322251344130 PMC12182627
Parent mention

Related peptide identities

PEPDIA-PLP-001878

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.